The inflammasome adaptor ASC contributes to innate immunity through the activation of caspase-1. Here we found that signaling pathways dependent on the kinases Syk and Jnk were required for the activation of caspase-1 via the ASC-dependent inflammasomes NLRP3 and AIM2. Inhibition of Syk or Jnk abolished the formation of ASC specks without affecting the interaction of ASC with NLRP3. ASC was phosphorylated during inflammasome activation in a Syk-and Jnk-dependent manner, which suggested that Syk and Jnk are upstream of ASC phosphorylation. Moreover, phosphorylation of Tyr144 in mouse ASC was critical for speck formation and caspase-1 activation. Our results suggest that phosphorylation of ASC controls inflammasome activity through the formation of ASC specks.
A r t i c l e s
Inflammasomes are large multiprotein oligomers that serve critical roles in host defense against microbial pathogens and the development of inflammatory disorders by facilitating the secretion of proinflammatory cytokines 1 . Core components of each inflammasome are pro-caspase-1 and a cytosolic pattern-recognition receptor belonging to the Nod-like receptor (NLR) family or the HIN-200 family, which contains a pyrin domain or a caspase-recruitment domain (CARD). Inflammasome complexes are believed to be assembled after the recognition of specific stimuli by the receptors 2, 3 . Once assembled, inflammasomes serve as platforms for the activation of caspase-1, which in turn cleaves the precursor forms of interleukin-1β (IL-1β) and IL-18 to their bioactive forms 4 .
Different subsets of inflammasomes are activated by different stimuli. The NLRC4 inflammasome is activated by flagellin and the type III secretion apparatus from bacteria [5] [6] [7] . Anthrax lethal toxin produced by Bacillus anthracis triggers activation of the NLRP1B inflammasome in mouse macrophages 8 . Activation of the NLRP3 inflammasome depends on a priming step (signal 1) and an activation step (signal 2) 9 . Signal 1 can be induced by signaling via Toll-like receptors, whereas signal 2 is induced by microbial components with diverse molecular structures, such as microbial RNA and toxins 10, 11 . In addition, the adjuvant alum and endogenous danger-associated molecules, including ATP and monosodium urate (MSU) crystals, also induce signal 2 for the activation of the NLRP3 inflammasome 10, 12, 13 . AIM2 and IFI16 sense cytosolic DNA and nuclear DNA, respectively, and DNA viruses 14 , Francisella tularensis 15 , Listeria monocytogenes 16, 17 and Streptococcus pneumoniae 18 have been demonstrated to activate the AIM2 inflammasome or IFI16 inflammasome 19 in host cells.
The adaptor ASC (PYCARD or TMS-1) is composed of a pyrin domain and a CARD and contributes to the assembly of inflammasome complexes 20 . ASC serves as the bridge between pro-caspase-1 and pyrin-containing inflammasomes, such as NLRP3 and AIM2. Accordingly, NLRP3 and AIM2 require ASC exclusively for the recruitment of pro-caspase-1, while the CARD-containing receptors NLRC4 and NLRP1 can directly interact with pro-caspase-1 (refs. 1, 7, 21) . During inflammasome activation, ASC also forms cytosolic macromolecular aggregates of ASC dimers called ' ASC specks' , ' ASC foci' or 'pyroptosomes' 22, 23 . The ASC speck recruits and activates procaspase-1, which leads to the secretion of large amounts of IL-1β and IL-18 and to pyroptosis, a form of programmed cell death. However, ASC is not always essential for cytokine processing and the induction of pyroptosis via the NLRC4 inflammasome. In addition to proteinprotein interactions in inflammasome complexes, published reports have revealed the involvement of type I interferons 15, 24 , the ubiquitin ligase-associated protein SGT1, the heat-shock protein hsp90 (ref. 25) , unidentified serine proteases 26 and kinases [27] [28] [29] [30] [31] [32] [33] , such as PKC-δ, PKR, Syk, Lyn, PI(3)K, Erk and DAPK, in the activation or regulation of inflammasomes, but how these molecules participate in inflammasome activity remains largely unclear.
Given the importance of the protective and pathological roles of inflammasomes, it is worth clarifying what and how signaling factors are involved in the activation of inflammasomes. Here we found that the NLRP3 and AIM2 inflammasomes, but not the NLRC4 inflammasome, required Syk and Jnk for their full activity. Inhibition of Syk or Jnk abolished the NLRP3-or AIM2-mediated formation of ASC specks without affecting the interaction between ASC and NLRP3. 
We also found that ASC underwent Syk-and Jnk-dependent phosphorylation and that Tyr144, one of the possible phosphorylation sites, was critical for speck formation. Our results indicate the phosphorylation of ASC may be an additional target for controlling inflammasome activity.
RESULTS

NLRP3 and AIM2 require Syk and Jnk for IL-18 secretion
To examine the role of kinases in inflammasome activation, we assessed the effects of a series of common kinase inhibitors (Supplementary Table 1 ) on the NLRP3, AIM2 and NLRC4 inflammasomes in peritoneal macrophages. To rule out the possibility of effects of the inhibitors on signal 1 delivered by priming with lipopolysaccharide (LPS), we added the inhibitors to macrophage cultures 3 h after the initiation of LPS priming. Those inhibitors did not affect the abundance of the inflammasome components or of pro-IL-18 or pro-IL-1β at the protein level (Supplementary Fig. 1a) . We measured IL-18 secretion as an indicator of caspase-1 activation, as pro-IL-18, unlike pro-IL-1β, is constitutively expressed in macrophages 31 . The nigericin-induced secretion of IL-18 from macrophages was significantly lower after pretreatment with an inhibitor of Syk or Jnk, but not after pretreatment with inhibitors of other kinases, than after pretreatment with dimethyl sulfoxide, as a control (Fig. 1a) . We obtained similar results with mouse bone marrowderived macrophages and the U937 human macrophage cell line ( Supplementary Fig. 1b,c) , which excluded the possibility of macrophage type-and species-specific effects. The production of IL-18 induced by alum, another NLRP3 activator, was also diminished by pretreatment with an inhibitor of Syk or Jnk (Supplementary Fig. 1e ), which suggested that Syk and Jnk contributed to activation of the NLRP3 inflammasome. Moreover, we found that the production of IL-18 induced by the synthetic B-form double-stranded DNA poly(dA:dT), but not that induced by flagellin, was substantially inhibited by pretreatment with an inhibitor of Syk or Jnk (Fig. 1b,c) .
To confirm the role of Syk and Jnk in this, we used small interfering RNA to knock down the expression of Syk or the genes encoding Jnk1 and Jnk2 (Mapk8-Mapk9) in macrophages, and also assessed macrophages with knockout of Syk, Mapk8 or Mapk9, and found that either knockdown or knockout decreased the secretion of IL-18 in response to nigericin or poly(dA:dT) (Fig. 1d-h and Supplementary  Fig. 2a-d) . Also, the nigericin-induced secretion of IL-1β from macrophages was reduced by an inhibitor of Syk or Jnk or knockout of either Syk or Mapk8-Mapk9 ( Fig. 1e and Supplementary Fig. 1d ). Those observations suggested involvement of Syk and Jnk in activation of the NLRP3 and AIM2 inflammasomes. Syk deficiency in macrophages resulted in a moderate decrease in the secretion of IL-18 and IL-1β induced by nigericin (Fig. 1d,e) , which indicated that Syk was not a critical requirement for activation of the NLRP3 inflammasome but instead contributed to that. Salmonella enterica serovar Typhimurium 14028 (S. Typhimurium) and Mycobacterium tuberculosis strain H37Rv are recognized mainly by NLRC4 and NLRP3, respectively, while Listeria monocytogenes strain EGD is recognized by various receptors, including AIM2 and NLRP3 (refs. 6,17,33) . Consistent with the results reported above obtained by stimulation by ligands, IL-18 production induced by S. Typhimurium was not affected much by inhibition of Syk or Jnk in macrophages, whereas IL-18 production induced by M. tuberculosis or L. monocytogenes was reduced by inhibition of Syk or Jnk (Fig. 1i-k) . From these npg kinases (Fig. 2a,b and Supplementary Fig. 1f ). In contrast, we did not observe effects of those two inhibitors on the activation of caspase-1 induced by flagellin or S. Typhimurium (Fig. 2c,d ). Furthermore, activation of caspase-1 induced by nigericin or poly(dA:dT) was reduced in Syk-or Jnk-deficient macrophages and by knockdown of those kinases results, we concluded that Syk and Jnk contributed to the activity of the NLRP3 and AIM2 inflammasomes but not that of the NLRC4 inflammasome. A r t i c l e s mediated by small interfering RNA (Fig. 2e-h and Supplementary  Fig. 2e,f) . The activation of caspase-1 induced by M. tuberculosis or L. monocytogenes in macrophages was lower after treatment with an inhibitor Syk or Jnk than after treatment with the dimethyl sulfoxide control (data not shown). These results suggested that Syk and Jnk signals were involved in the activation of caspase-1 through the NLRP3 and AIM2 inflammasomes but not in the NLRC4 inflammasomedependent activation of caspase-1.
Caspase-1 activation requires Syk and Jnk
Syk is not required for NLRP3 inflammasome in dendritic cells
It has been reported that Syk is not required for nigericin-induced activation of the NLRP3 inflammasome in dendritic cells 28 . Consistent with that report, we observed no significant difference between wild-type and Syk-deficient bone marrow-derived dendritic cells in caspase-1 activation or IL-18 secretion in response to nigericin (Supplementary Fig. 3a,c,d ). In contrast, IL-18 secretion and caspase-1 activation induced by nigericin were lower in Syk-deficient peritoneal macrophages and bone marrow-derived macrophages than in Syk +/+ or Syk +/− cells (Figs. 1d,e and 2e and Supplementary  Fig. 3b,e) . This suggested that the requirement for Syk in NLRP3 activation in response to nigericin was cell type specific.
Syk and Jnk regulate inflammasomes via unknown pathways
We investigated whether inflammasome-activating agents induced activation of Syk and Jnk, assessed by the detection of phosphorylated kinases. Stimulation with nigericin or poly(dA:dT) induced detectable levels of phosphorylated Syk and Jnk (Supplementary Fig. 4a-d) . The phosphorylation of Jnk induced by nigericin or poly(dA:dT) was not reduced by inhibitors of Syk or in Syk-deficient peritoneal macrophages ( Supplementary Fig. 4e-g ), which suggested that Syk is not upstream of Jnk in this process. Syk is reported to serve a pivotal role in activation of the NLRP3 inflammasome in response to Candida albicans by inducing the generation of reactive oxygen species (ROS) and CARD9-dependent activation of the transcription factor NF-κB 28 . However, we 
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A r t i c l e s observed that wild-type and CARD9-deficient macrophages produced similar levels of IL-18 in response to nigericin or poly(dA:dT) and that the ROS scavenger BHA did not affect activation of the AIM2 inflammasome in macrophages ( Supplementary Fig. 4h-j) . Moreover, the expression of mitochondrial ROS, which is important for the activation of NLRP3, was not reduced by an inhibitor of Syk or Jnk in nigericinstimulated macrophages (Supplementary Fig. 4k ). These results indicated that Syk-and Jnk-dependent activation of the inflammasome is not mediated by ROS or CARD9 and that Syk and Jnk operate in a different pathway(s).
The formation of ASC specks requires Syk and Jnk Both NLRP3 and AIM2 require the common adaptor ASC to recruit and activate pro-caspase-1 (ref. 1). We therefore speculated that Syk and Jnk might be involved in the interaction of ASC with NLRP3 or AIM2. To investigate that possibility, we visualized ASC-NLRP3 complexes by an in situ proximity ligation assay (PLA). As reported before 30 , we observed small spots of ASC-NLRP3 complexes in peritoneal macrophages, and these increased in abundance after stimulation with nigericin (Fig. 3a) . The abundance of spots was not increased by stimulation with nigericin in the absence of ASC or NLRP3 (data not shown), which suggested that ASC-NLRP3 complexes were specifically visualized by this technique. After stimulation with nigericin, the number of spots representing ASC-NLRP3 complexes was similar in macrophages pretreated with an inhibitor of Syk or Jnk and those pretreated with dimethyl sulfoxide (Fig. 3a,b) , which indicated that inhibition of Syk or Jnk did not affect the interaction between NLRP3 and ASC, a critical step in formation of the NLRP3 inflammasome, in macrophages stimulated with nigericin. Next we visualized the formation of ASC specks and found that pretreatment with an inhibitor of Syk or Jnk or deficiency in either Syk or Jnk reduced the nigericin-induced formation of ASC specks in macrophages (Fig. 3c-f and Supplementary Fig. 5a,b) . Because ASC has been reported to form Triton X-100-resistant aggregates 20 , we prepared Triton X-100-soluble and Triton X-100-insoluble fractions from macrophages to analyze the distribution of ASC. ASC was almost undetectable in the Triton X-100-insoluble fraction of LPS-primed macrophages but was significantly greater in abundance after stimulation with nigericin (Fig. 3g) . Moreover, most ASC in the Triton X-100-insoluble fraction was a dimer or oligomer 15 (Fig. 3h) . Pretreatment with an inhibitor of Syk or Jnk reduced the redistribution of ASC induced by nigericin and also resulted in a decrease in the amount of dimerized and oligomerized ASC (Fig. 3g,h) . We obtained similar results for macrophages stimulated with poly(dA:dT) (Fig. 3i,j and Supplementary Fig. 5c-f) . These results suggested that signaling by Syk and Jnk was required for the formation of ASC specks but not for the NLR-ASC interaction. 
A r t i c l e s
Phosphorylation of ASC after inflammasome activation A published report has implied that ASC undergoes phosphorylation in response to inflammatory stimuli 34 . To investigate whether the aggregate formation of ASC was regulated by its phosphorylation mediated by Syk and Jnk during inflammasome activation, we enriched phosphorylated proteins from macrophage lysates through the use of a column containing a phosphorylated protein-binding resin and then detected ASC by immunoblot analysis. We observed that stimulation with nigericin induced an increase in the amount of ASC in the elution fraction (with enrichment for phosphorylated proteins; Fig. 4a ). To further analyze the phosphorylation of ASC, we obtained Triton X-100-soluble and Triton X-100-insoluble cell lysates and analyzed them by a mobility-shift assay (MSA) based on the phosphate-binding tag Phos-tag 35 . In these gels, ASC in the Triton X-100-insoluble fraction migrated more slowly than that in the Triton X-100-soluble fraction, and the shift in mobility was reversed by phosphatase treatment (Fig. 4b,c) , which suggested that ASC in the former fraction was phosphorylated. We observed the slowly migrating ASC in the Triton X-100-insoluble fraction of caspase-1-deficient macrophages but not in that of NLRP3-deficient macrophages, after stimulation with nigericin (Fig. 4b) , which suggested that the increase in phosphorylated ASC in response to nigericin required NLRP3 but not caspase-1. ASC may be phosphorylated at multiple sites, as we detected three major bands with different mobility (Fig. 4c-g ).
In addition, deficiency in either Syk or Jnk decreased the intensity of the ASC band with the lowest mobility in the Triton X-100-insoluble fraction of macrophages stimulated with nigericin or poly(dA:dT) (Fig. 4d-g ). We obtained similar results with an inhibitor of Syk or Jnk (data not shown). These data suggested that ASC was phosphorylated after activation of the NLRP3 and AIM2 inflammasomes via the Syk and Jnk pathways. Syk and DAPK have been shown to associate with the NLRP3 inflammasome complex 29, 30 . Accordingly, we analyzed the interaction of ASC with phosphorylated Jnk by in situ PLA. We observed complexes of ASC with phosphorylated Jnk in wild-type macrophages (Fig. 4h-k) , but not in ASC-deficient macrophages (negative control; data not shown), after stimulation with nigericin or poly(dA:dT). Notably, most of the complexes were located in or around the nucleus at later time points (Fig. 4h,j) . These data suggested that ASC was phosphorylated after activation of the NLRP3 and AIM2 inflammasomes via the Syk and Jnk pathways.
Phosphorylation of ASC is critical for inflammasome activation
We next sought to identify ASC-phosphorylation sites that regulate the aggregate formation that results in activation of caspase-1. We detected 14 or 8 possible phosphorylation sites, respectively, in mouse ASC with NetPhos (a neural network-based method for predicting potential phosphorylation sites at serine, threonine or tyrosine residues; version 2.0), at a threshold of 0.5, or with GPS (a group-based prediction system for the computational prediction of phosphorylation sites with their cognate kinases; version 2.1.1) with the low threshold ( Supplementary Fig. 6 and Supplementary Table 2 ). We constructed a series of expression vectors encoding ASC npg mutants in which amino acid residues predicted to be phosphorylated were replaced with alanine or phenylalanine, then assessed the ability of those ASC point mutants to induce IL-1β secretion in an inflammasome-reconstitution system based on HEK293 human embryonic kidney cells (Supplementary Fig. 7a,b) . We observed that the ability of the point mutants ASC(S58A), ASC(T125A), ASC(Y144F) or ASC(T151A,T152A,S153A) to induce IL-1β secretion in response to NLRP3(R258W), a disease-associated mutant of NLRP3, was slightly lower that of wild-type ASC (Fig. 5a,b) . We further altered the ASC(S58A) mutant by the additional substitution T125A or with the three additional substitutions of T151A, T152A and S153A (ASC(58,151-153)) and found that IL-1β-inducing ability of the resulting ASC mutants was significantly lower than that of ASC(S58A) (Fig. 5b) . Furthermore, ASC(Y144F) and ASC(58,151-153) showed less redistribution into the Triton X-100-insoluble fraction in response to NLRP3(R258W) than did wild-type ASC (Fig. 5c,d) . ASC(Y144F) and ASC(58,151-153) were still able to form dimers and oligomers in the Triton X-100-insoluble fraction (Fig. 5e) , probably because those substitutions affected the redistribution of ASC without affecting its dimerization or oligomerization. Moreover, we found that ASC(Y144F) expressed together with NLRP3(R258W) formed almost no aggregates, in contrast to wild-type ASC expressed together with NLRP3(R258W) (Fig. 5f) . These results suggested that Tyr144, Ser58, Thr151, Thr152 and Ser153, all putative phosphorylation sites of ASC, were involved in both IL-1β-inducing ability and aggregate formation.
We investigated whether those results obtained with HEK293 cell could be reproduced in the mouse macrophage cell line RAW264.7, which lacks ASC expression. Wild-type ASC expressed together with NLRP3(R258W) in RAW264.7 cells formed speck-like structures and induced the activation of caspase-1, whereas speck formation was diminished in RAW264.7 cells transfected to express ASC(Y144F) or ASC(58,151-153) (Fig. 6a-c) . The formation of ASC specks was also abrogated by the substitutions in similar experiments with ASCdeficient primary macrophages (Fig. 6d) .
We further investigated whether those residues were phosphorylated in a Syk-and Jnk-dependent manner. ASC expressed together with either Syk or Jnk migrated more slowly in Phos-tag gels than did ASC in cells transfected with empty vector (Fig. 7a) . Transfection of cells to express ASC with both Syk and Jnk resulted in a greater mobility shift, which was reversed by phosphatase treatment (Fig. 7a,b) . These results suggested that ASC was phosphorylated at multiple sites in a Syk-and Jnk-dependent manner. The observed changes in the mobility of ASC in the presence of Syk or Jnk were all abrogated by the Y144F substitution in ASC (Fig. 7c) . In contrast, the mobility of ASC(S58A), ASC(T151A,T152A,S153A) and ASC(58,151-153) in Phos-tag gels, like that of wild-type ASC, was reduced by overexpression of Jnk1-Jnk2 (Fig. 7d) , which suggested that Ser58, Thr151, Thr152 and Ser153 were not phosphorylated in a Jnk-dependent manner or that the effect of those substitutions on the mobility may have been masked by phosphorylation at other residues. These results showed that phosphorylation of Tyr144 was required for inflammasome activation.
We did in vitro kinase assays with synthetic peptides (amino acids 139-150 of mouse ASC or amino acids 141-152 of human ASC) to investigate the possibility that Syk directly phosphorylates Tyr144 of mouse ASC and the corresponding tyrosine residue of human ASC. We incubated those peptides with ATP in the presence or absence of recombinant Syk and assessed the kinase reaction by the consumption of ATP. We did not observe substantially less ATP in reactions in which we used those ASC peptides as a substrate for recombinant Syk, whereas reactions containing purified tubulin, as a positive control substrate, had less ATP (data not show). Thus, our data did not support or were not sufficient to justify the possibility of direct phosphorylation of Tyr144 by Syk.
MSU-and alum-induced peritonitis is dependent on Syk and Jnk
Next we investigated whether Syk and Jnk were required for inflammasome activation in vivo. We analyzed the recruitment of inflammatory cells into the peritoneal cavity as an indicator of stimulant-induced inflammation after intraperitoneal injection of mice with MSU or alum. As shown before 12, 29 , both MSU and alum strongly induced the recruitment of cells, including Gr-1 + F4/80 − neutrophils and F4/80 + monocytes and macrophages, in an ASCdependent manner (Supplementary Fig. 8a-f) . We then reconstituted irradiated wild-type mice with fetal liver cells to generate Syk +/− and Syk −/− chimeras or with bone marrow cells to generate wild-type, Mapk8 −/− and Mapk9 −/− chimeras. After challenge with MSU or alum, Syk −/− chimeras had fewer total cells, neutrophils, and monocytes-macrophages in the peritoneal cavity than did Syk +/− chimeras (Fig. 8a,b,d-f ). After challenge with MSU, the number of peritoneal monocytes-macrophages tended to be lower in Syk −/− chimeras than in Syk +/− chimeras, but the difference between the groups was not statistically significant (Fig. 8c) . The infiltration of inflammatory cells induced by MSU or alum was also lower in Mapk8 −/− chimeras or in wild-type mice treated with 
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A r t i c l e s an inhibitor of Jnk than in wild-type chimeras or wild-type mice treated with vehicle only, respectively (Fig. 8g-i and Supplementary  Fig. 8a-f) . In contrast, the inflammasome-independent infiltration of inflammatory cells induced by chemokine CXCL1 (KC) was similar in Syk +/− and Syk −/− chimeras and in Mapk8 +/+ and Mapk8 −/− chimeras ( Supplementary Fig. 8g-l) , and the inhibitor of Jnk did not reduce the infiltration of inflammatory cells induced by alum in ASC-deficient mice (n = 3; data not shown). These results suggested that signaling via Syk and Jnk was involved in the MSUand alum-induced infiltration of inflammatory cells that was largely dependent on ASC.
DISCUSSION
The phosphorylation and dephosphorylation of proteins is important in controlling a wide range of biological processes, including innate and adaptive immunity and apoptosis 36, 37 . The involvement of kinases such as PKC-δ, PKR, Syk, Lyn, PI(3)K, Erk and DAPK in inflammasome activation has been reported, yet the precise mechanism of their action has remained unclear. In particular, Syk has been demonstrated to contribute to the NLRP3 inflammasome in response to C. albicans, most probably due to its role in inducing ROS production 28, 29, 31, 33 . NLRC4 is phosphorylated after stimulation with its ligands, and that phosphorylation is critical for inflammasome activation 27 . Here we showed that Syk and Jnk were involved in the activity of ASC-containing inflammasomes in macrophages via a mechanism that regulated the formation of ASC specks. We found that ASC was phosphorylated in a Syk-and Jnk-dependent manner at multiple sites, which most probably included Tyr144, which was essential for speck formation. The phosphorylation of ASC during inflammasome activation was required for activity of the NLRP3 and AIM2 inflammasomes. Thus, inflammasomes are regulated by protein kinases and perhaps by phosphatase(s) that target phosphorylated inflammasome components. We identified Tyr144 of ASC as a critical residue for speck formation and a possible phosphorylation site. Consistent with that, phosphorylation of the corresponding residue in human ASC (Tyr146) has been disclosed in a patent application (Hornbeck, P. et al., US patent application 2009/0325189 A1). The Y144F substitution in ASC completely abrogated the phosphorylation of ASC induced by overexpression of Syk or Jnk, which suggested that Tyr144 serves as a regulator of ASC phosphorylation mediated by those kinases. That tyrosine residue is evolutionary conserved. Tyr144 is located in the CARD, whereas published studies have shown that the pyrin domain of ASC is phosphorylated after stimulation with tumor-necrosis factor 34 , which suggests the existence of other phosphorylation sites that might also contribute to inflammasome activity.
It remains unclear how signaling via Syk and Jnk regulates the formation of ASC specks. Transfection of HEK293 cells to express ASC together with Syk or Jnk or both did not result in the formation of ASC specks or the redistribution of ASC to the Triton X-100-insoluble fraction (data not shown), which suggested that phosphorylation of ASC itself was not sufficient to induce speck formation in the absence of stimuli of the inflammasome. Our results also suggested a crucial role for Syk and Jnk in the redistribution, rather than the dimerization or oligomerization, of ASC upon inflammasome activation. During the generation of ASC aggregates, monomeric ASC, which is diffusely distributed before stimulation, is rapidly translocated to a perinuclear speck in each cell. The formation of ASC specks is prevented by treatment with nocodazole, and ASC specks are located near the microtubule-organizing center 38 , which suggests a possible role for microtubules in the migration of ASC during the step of speck formation. In our assays, most complexes of ASC and phosphorylated Jnk were located in or around the nucleus, and ASC remained diffusely distributed in the cytosol even after inflammasome activation in cells in which Syk or Jnk was inhibited genetically or pharmacologically. Thus, we speculate that Syk-and Jnk-mediated ASC phosphorylation may function as a molecular 'switch' that controls the migration of ASC along microtubules to the site of speck formation. Together, these results indicate that ASC speck formation is a consequence of multiple cellular events orchestrated by inflammasome receptors, Syk, Jnk and perhaps microtubules.
Although inflammasomes have pivotal roles in innate immunity to pathogens, excessive or dysregulated activation of inflammasomes, especially the NLRP3 inflammasome, has been linked to various autoinflammatory diseases and autoimmune diseases, including Muckle-Wells syndrome, inflammatory bowel diseases 39, 40 , vitiligo 41 and rheumatoid arthritis 12 . Inflammasomes have also been linked to obesity-induced insulin resistance 42 , atherosclerosis 43 and gouty arthritis 44 and could represent potential targets for therapy. Therapies involving antibody to IL-1β appear to be effective in treating inflammatory disorders associated with deregulated inflammasome activity, and further understanding of the basic processes and mechanisms involved in inflammasome activation will provide additional strategies for controlling autoinflammatory conditions. Here we have shown that phosphorylation of the inflammasome component ASC regulates inflammasome activity. Thus, for example, compounds designated to specifically inhibit the phosphorylation of ASC may be promising drug candidates for the treatment of inflammasomeassociated diseases, and antibodies specific to phosphorylated ASC may be useful for diagnostic and research purposes. Further investigation of the inflammasome will reveal the precise roles of kinases in inflammasome activation and may identify additional mechanisms for controlling inflammasome activity.
METHODS
Methods and any associated references are available in the online version of the paper. 
